Article Versions Notes

Rasul S, Wollenweber T, Zisser L, Kretschmer-Chott E, Grubmüller B, Kramer G, Shariat SF, Eidherr H, Mitterhauser M, Vraka C, et al. Response and Toxicity to the Second Course of 3 Cycles of ¹⁷⁷Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers. 2021; 13(10):2489. https://doi.org/10.3390/cancers13102489

Rasul, Sazan, Tim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, Bernhard Grubmüller, Gero Kramer, Shahrokh F. Shariat, Harald Eidherr, Markus Mitterhauser, Chrysoula Vraka, and et al. 2021. "Response and Toxicity to the Second Course of 3 Cycles of ¹⁷⁷Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer" Cancers 13, no. 10: 2489. https://doi.org/10.3390/cancers13102489

Rasul, S., Wollenweber, T., Zisser, L., Kretschmer-Chott, E., Grubmüller, B., Kramer, G., Shariat, S. F., Eidherr, H., Mitterhauser, M., Vraka, C., Langsteger, W., Hacker, M., & Haug, A. R. (2021). Response and Toxicity to the Second Course of 3 Cycles of ¹⁷⁷Lu-PSMA Therapy Every 4 Weeks in Patients with Metastatic Castration-Resistant Prostate Cancer. Cancers, 13(10), 2489. https://doi.org/10.3390/cancers13102489